234 related articles for article (PubMed ID: 21144490)
21. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
[TBL] [Abstract][Full Text] [Related]
22. Calibration of replacement international standard and European Pharmacopoeia Biological Reference Preparation for Diphtheria Toxoid, Adsorbed.
Sesardic D; Winsnes R; Rigsby P; Gaines-Das R
Biologicals; 2001 Jun; 29(2):107-22. PubMed ID: 11580215
[TBL] [Abstract][Full Text] [Related]
23. Collaborative study for the establishment of replacement batches of heparin low- molecular-mass for assay biological reference preparations.
Terao E; Daas A; Rautmann G; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):30-6. PubMed ID: 21144487
[TBL] [Abstract][Full Text] [Related]
24. Collaborative study for the establishment of the Ph. Eur. BRP for oral poliomyelitis vaccine (OPV) Batch 3 for use in the potency assay.
Buchheit KH; Daas A; Stalder J
Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):67-91. PubMed ID: 12448032
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis A immunoglobulin: an international collaborative study to establish the second international standard.
Ferguson M; Sands D; Lelie N
Biologicals; 2000 Dec; 28(4):233-40. PubMed ID: 11237359
[TBL] [Abstract][Full Text] [Related]
26. Collaborative study for the establishment of replacement batches for human coagulation factor IX concentrate reference standards.
Gray E; Pickering W; Hockley J; Rigsby P; Weinstein M; Terao E; Buchheit KH
Pharmeuropa Bio; 2008 Dec; 2008(1):19-30. PubMed ID: 19220978
[TBL] [Abstract][Full Text] [Related]
27. Establishment of European Pharmacopoeia BRP batch 2 for inactivated poliomyelitis vaccine for in vitro D antigen assay.
Fuchs F; Minor P; Daas A; Milne C
Pharmeuropa Bio; 2003 Jul; 2003(1):23-50. PubMed ID: 14563307
[TBL] [Abstract][Full Text] [Related]
28. An international collaborative study to replace the 1st international standard for prekallikrein activator.
Longstaff C; Behr-Gross ME; Daas A; Lackner F
Vox Sang; 2005 Feb; 88(2):143-51. PubMed ID: 15720613
[TBL] [Abstract][Full Text] [Related]
29. Establishment of replacement batches for heparin low-molecular-mass for calibration CRS, and the International Standard Low Molecular Weight Heparin for Calibration.
Mulloy B; Heath A; Behr-Gross ME
Pharmeuropa Bio; 2007 Dec; 2007(1):29-48. PubMed ID: 18413136
[TBL] [Abstract][Full Text] [Related]
30. A collaborative study to establish the 3rd International Standard for tissue plasminogen activator.
Sands D; Whitton CM; Merton RE; Longstaff C
Thromb Haemost; 2002 Aug; 88(2):294-7. PubMed ID: 12195703
[TBL] [Abstract][Full Text] [Related]
31. Standardization of Factor VIII-IV. Establishment of the 3rd International Standard for Factor VIII: C concentrate.
Barrowcliffe TW; Curtis AD; Thomas DP
Thromb Haemost; 1983 Oct; 50(3):697-702. PubMed ID: 6417819
[TBL] [Abstract][Full Text] [Related]
32. The 2nd International Standard for human granulocyte colony stimulating factor.
Wadhwa M; Bird C; Hamill M; Heath AB; Matejtschuk P; Thorpe R;
J Immunol Methods; 2011 Mar; 367(1-2):63-9. PubMed ID: 21334342
[TBL] [Abstract][Full Text] [Related]
33. Calibration of human coagulation factor VII concentrate Ph. Eur. BRP batch 2.
Dodt J; Costanzo A; Daas A; Hunfeld A; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):31-8. PubMed ID: 20223188
[TBL] [Abstract][Full Text] [Related]
34. A collaborative study to establish the 5th International Standard for Unfractionated Heparin.
Gray E; Walker AD; Mulloy B; Barrowcliffe TW
Thromb Haemost; 2000 Dec; 84(6):1017-22. PubMed ID: 11154108
[TBL] [Abstract][Full Text] [Related]
35. Collaborative study to assess the suitability of a candidate International Standard for yellow fever vaccine.
Ferguson M; Heath A
Biologicals; 2004 Dec; 32(4):195-205. PubMed ID: 15572101
[TBL] [Abstract][Full Text] [Related]
36. Establishment of new and replacement World Health Organization International Biological Standards for human interferon alpha and omega.
Meager A; Gaines Das R; Zoon K; Mire-Sluis A
J Immunol Methods; 2001 Nov; 257(1-2):17-33. PubMed ID: 11687235
[TBL] [Abstract][Full Text] [Related]
37. An international collaborative study to establish the 2nd World Health Organization International Standard for hepatitis B virus DNA nucleic acid amplification technology-based assays.
Baylis SA; Heath AB; Chudy M; Pisani G; Klotz A; Kerby S; Gerlich W
Vox Sang; 2008 May; 94(4):358-62. PubMed ID: 18266781
[TBL] [Abstract][Full Text] [Related]
38. An international collaborative study to establish the WHO 1st international standard for alpha-1-antitrypsin.
Thelwell C; Marszal E; Rigsby P; Longstaff C
Vox Sang; 2011 Jul; 101(1):83-9. PubMed ID: 21668863
[TBL] [Abstract][Full Text] [Related]
39. A World Health Organization International Standard for hepatitis A virus RNA nucleic acid amplification technology assays.
Saldanha J; Heath A; Lelie N; Pisani G; Yu MY;
Vox Sang; 2005 Jul; 89(1):52-8. PubMed ID: 15938741
[TBL] [Abstract][Full Text] [Related]
40. International collaborative study to establish reference preparations to standardise haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulins by the direct method.
Thorpe SJ; Fox B; Sharp G; Heath AB; Behr-Gross ME; Terao E; Virata-Theimer ML; Yu MW
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):39-50. PubMed ID: 20223189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
